IPO Stock Watch: Regenxbio Jumps On First Trading Day
Regenxbio (RGNX) popped on the first trading day of its upsized initial public offering, which raised $138.6 million for the drugmaker. Regenxbio priced at 22 and opened at 30.26, up 38%, and remained near there in midday trading. It had previously set a price range of 17 to 19. The biotech company offered 6.3 million shares, above previous plans to offer 5.6 million shares. Regenxbio is focused on developing, commercializing and licensing